DLCL
DR LALCHANDANI LABS LIMITEDHealthcare
LTP
7.17
CHG · %
-0.37 (-4.91%)
VOL · TODAY
4.00K
PREV CLOSE
7.54
Today's range7.17 · 7.17
7.17
52-week range7.17 · 21.21
7.17
Loading candles…
Dr. Lalchandani Labs Ltd was incorporated in 2011 and operates primarily in the diagnostics and healthcare industries. The company manages a network of laboratories and collection centers mainly within the Delhi/NCR region. Its core business segments include laboratory services, pathological investigations, radiology, hospital lab management, and corporate health check-ups. Dr. Lalchandani Labs Ltd provides pathology and radiology services while also handling hospital lab operations and health screenings for corporate clients. It serves individual patients, corporate entities, and government bodies, and is empaneled with major panels including the Central Government Health Scheme (CGHS) and the Delhi Jal Board. The company has no publicly listed exchanges, subsidiaries, or ventures reported.
DLCL is not part of any active scan today.
This page is a live market overview for DR LALCHANDANI LABS LIMITED (DLCL) on the BSE. As a listed security, DR LALCHANDANI LABS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for DLCL before placing trades on tick2trade.
As of the latest feed, DLCL last traded at ₹7.17 on BSE, down ₹0.37 (4.91%) from the previous close of ₹7.54. Today's session range is ₹7.17 – ₹7.17, against a 52-week band of ₹7.17 – ₹21.21. Traded volume today stands at 4.00K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for DLCL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether DLCL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for DR LALCHANDANI LABS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in DLCL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated DLCL option chain page linked from this overview.
// similar in healthcare314 total